ERNA - Eterna Therapeutics Inc logo

Eterna Therapeutics Inc

ERNA
βš•οΈ Healthcare NASDAQ Listed 1992 $ USD
$1,000 invested 30 years ago β†’$0today

Score Overview

1 Year
Scoreβ€”
Net Growth0.89%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growthβ€”
Rev TrendShrank
Revenue Consistencyβ€”
5 Years
Scoreβ€”
Net Growth88.61%
Net Trend80%
Net Income Consistencyβ€”
Rev Growthβ€”
Rev Trend40%
Revenue Consistencyβ€”
10 Years
Score
Net Growth-377.52%
Net Trend70%
Net Income Consistency
Rev Growth-100.00%
Rev Trend30%
Revenue Consistency
20 Years
Score2.3
Net Growth-192.44%
Net Trend59%
Net Income Consistency
Rev Growth-100.00%
Rev Trend29%
Revenue Consistency
All Time
Score
Net Growth-192.44%
Net Trend59%
Net Income Consistency
Rev Growth-100.00%
Rev Trend29%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where Eterna Therapeutics Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • ERNA

2020: 94.8% Β· 2021: 72.0% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 1.63β€”
1 Year2025-11-17
$ 37.75-95.68%
5 Years2021-11-17
$ 56.7K-100.00%
10 Years2016-11-17
$ 109.8K-100.00%
20 Years2006-11-17
$ 18.6K-99.99%
30 Years1996-11-15
$ 56.25K-100.00%
All Time1992-10-19
$ 56.25K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 0.00-$ 13M$ 5M
2025$ 0.00-$ 14M$ 1M
2024$ 582K-$ 44M$ 1M
2023$ 68K-$ 21M$ 7M
2022$ 0.00-$ 24M$ 11M
2021$ 0.00-$ 122M$ 16M
2020$ 5M$ 11M$ 1M
2019$ 19M-$ 2M$ 3M
2018$ 23M-$ 259K$ 2M
2017$ 21M-$ 1M$ 3M
2016$ 22M-$ 2M$ 5M
2015$ 24M-$ 7M$ 3M
2014$ 26M-$ 5M$ 7M
2013$ 23M-$ 1M$ 5M
2012$ 24M-$ 995K$ 2M
2011$ 23M-$ 3M$ 1M
2010$ 25M-$ 400K$ 3M
2009$ 25M-$ 1M$ 3M
2008$ 3M
2007$ 10M
2006$ 32M-$ 4M
ERNA - Eterna Therapeutics Inc logo

Eterna Therapeutics Inc fundamental performance

Between 2015 and 2025, revenue declined from $ 24M to $ 0.00 and net income went from -$ 7M to -$ 14M. Revenue increased in 3 of those 10 years; net income in 7.

Across Eterna Therapeutics Inc's full reported history, from 2006 to 2025, revenue declined from $ 32M to $ 0.00 and net income went from -$ 4M to -$ 14M. Revenue increased in 29% of the years measured; net income in 59%.

Eterna Therapeutics Inc currently holds a 20-year HDB Score of 2.3 out of 10. How the HDB Score is calculated.

Membership

Continue ERNA’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,187 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies